Due to the clinical evidence of dystrophin deficiency, genetic investigations were focused on the region of the DMD gene (CFAX: 26,290,714–28,333,431). This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.